NCT02355990已完成不适用
Minimally Invasive Micro Sclerostomy First in Man Safety and Preliminary Performance Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 96
- 试验地点
- 2
- 主要终点
- Overall incidence of serious adverse events
研究概览
简要总结
The study objective is to demonstrate the safety of Minimally Invasive Micro Sclerostomy (MIMS) device for lowering elevated IOP in patients diagnosed with glaucoma.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •End Stage primary open-angle glaucoma, pseudoexfoliation glaucoma or pigmentary glaucoma in the study eye (EGS criteria)
- •Optic nerve appearance characteristic of glaucoma in the study eye
- •Best-corrected visual acuity (BCVA) of counting-fingers, hand movements, light perception or no light perception due to glaucomatous loss of central vision in the study eye
- •Patient is treated with 1 to 5 hypotensive medications in the study eye
- •Unsatisfactory medicated IOP (≥ 18 mmHg) at the screening visit in the study eye
- •Shaffer grade ≥ III in all four angle quadrants in the study eye
- •Subject is able and willing to attend all scheduled follow-up exams
- •Subject understands and signs the informed consent
排除标准
- •Subjects presenting 1 or more of the following criteria will not be enrolled in the trial:
- •Ocular conditions with a poorer prognosis in the fellow eye than in the study eye
- •Closed angle forms of glaucoma in either eye
- •Congenital or developmental glaucoma in either eye
- •Other secondary glaucoma (such as neovascular, uveitic, lens-induced, trauma-induced, or glaucoma associated with increased episcleral venous pressure) in the study eye
- •Peripheral anterior synechiae (PAS), rubeosis or other angle abnormalities in the study eye
- •Subject has history of penetrating keratoplasty (PKP)
- •Any previous surgery in the study eye (except for clear corneal cataract surgery) where the conjunctiva is not intact and elastic.
- •Any ocular disease or history in study eye such as severe dry eye, active proliferative retinopathy, ICE syndrome, epithelial or fibrous down growth, and ocular pathology that may interfere with accurate IOP measurements
- •Prior surgery for an ab-interno or ab-externo device implanted in or through the Schlemm's canal in the study eye.
- •Use of oral hypotensive medication for glaucoma for treatment of the fellow eye
- •Less than the minimum visual function required for driving in the fellow eye: best-corrected visual acuity worse than 20/40 (Snellen equivalent) or Esterman visual field score less than 85%.
- •History of idiopathic or autoimmune uveitis in either eye
- •Severe trauma in study eye
- •active iris neovascularization, previous cyclodestructive procedure, prior scleral buckling procedure, presence of silicone oil, need for glaucoma surgery combined with other ocular procedures or anticipated need for additional ocular surgery in study eye within 12 month period
- •Vitreous present in anterior chamber, prior vitrectomy or virteous hemorrhage in study eye
- •Prior vitreoretinal surgery in study eye
- •Clinically significant ocular inflammation or infection within 90 days prior to screening
- •Unable to discontinue use of blood thinners in accordance with surgeon's standard preoperative instructions
- •Uncontrolled systemic disease that in the opinion of the investigator would put the subject's health at risk and/or prevent the subject from completing all study visits
- •Current participation or participation in another investigational drug or device clinical trial within the last 30 days before screening visit
- •Pregnant or lactating women
结局指标
主要结局
Overall incidence of serious adverse events
时间窗: 12 weeks
次要结局
- Incidence of serious adverse events(24 weeks)
- Change in number of glaucoma medications from baseline in the study eye(24 weeks)
- intraocular pressure (IOP) between 6 mmHg and 15 mmHg without medication(24 weeks)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Efficacy and Safety of Minimally Invasive Micro-Sclerostomy (MIMS) in Glaucoma SurgeryGlaucomaNCT06213805Hôpital Privé de la Baie23
已完成
不适用
Minimally Invasive Micro Sclerostomy (MIMS®) Inferonasal Procedure - Performance Evaluation StudyThis Study is Conducted Under Inclusion/ Exclusion CriteriaNCT05638321Sanoculis Ltd83
尚未招募
不适用
MIMS® Retrospective Chart ReviewOpen Angle GlaucomaNCT06614218Sanoculis Ltd40
招募中
不适用
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite PolypharmacyPrimary Open Angle GlaucomaOpen Angle GlaucomaNCT06313749Sanoculis Ltd129
Unknown
不适用
Safety Study of Minimally Invasive Approaches to Unruptured Anterior Circulation AneurysmsCerebral AneurysmAneurysm, Middle Cerebral ArteryAneurysm, Anterior Communicating ArteryAneurysm, Posterior Communicating ArteryAneurysm, Carotid ArteryBrain AneurysmNCT02345395University of Sao Paulo General Hospital120